Body Roundness Index Trajectory Tied to Risk for Cardiovascular Disease
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- A higher body roundness index (BRI) trajectory is associated with an increased risk for cardiovascular disease (CVD), according to a study published online Sept. 25 in the Journal of the American Heart Association.
Man Yang, M.D., from The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University in China, and colleagues examined the association of BRI trajectories with CVD among 9,935 middle-aged and older Chinese people in a longitudinal cohort. Group-based trajectory modeling was used to identify BRI trajectories.
Participants were classified into low-stable, moderate-stable, and high-stable BRI trajectories, accounting for 49.81, 42.35, and 7.84 percent of the study population, respectively. The researchers found that participants in the moderate-stable and high-stable BRI trajectory groups had an increased risk for CVD compared with participants in the low-stable trajectory group, with multivariable adjusted hazard ratios of 1.22 and 1.55, respectively. CVD risk reclassification was improved by simultaneously adding the BRI trajectory to the conventional risk model.
"The longitudinal trajectory of the BRI could be used as a novel indicator of CVD risk, providing a new possibility for CVD prevention," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Adverse Pregnancy Outcomes Partly Mediate Association Between Prepregnancy Obesity, CVD Risk
MONDAY, April 21, 2025 -- Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in...
Tirzepatide Dispensations Increased Rapidly After Approval
TUESDAY, April 15, 2025 -- After approval, tirzepatide dispensations increased markedly among adults with type 2 diabetes prescribed glucose-lowering medications (GLMs) and among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.